1ec0: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:1ec0.png|left|200px]] | [[Image:1ec0.png|left|200px]] | ||
{{STRUCTURE_1ec0| PDB=1ec0 | SCENE= }} | {{STRUCTURE_1ec0| PDB=1ec0 | SCENE= }} | ||
===HIV-1 protease in complex with the inhibitor bea403=== | ===HIV-1 protease in complex with the inhibitor bea403=== | ||
{{ABSTRACT_PUBMED_15560801}} | {{ABSTRACT_PUBMED_15560801}} | ||
==About this Structure== | ==About this Structure== | ||
[[1ec0]] is a 2 chain structure of [[Virus protease]] with sequence from [http://en.wikipedia.org/wiki/Human_immunodeficiency_virus_1 Human immunodeficiency virus 1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1EC0 OCA]. | |||
==See Also== | |||
*[[Virus protease|Virus protease]] | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:015560801</ref><references group="xtra"/> | ||
[[Category: HIV-1 retropepsin]] | [[Category: HIV-1 retropepsin]] | ||
[[Category: Human immunodeficiency virus 1]] | [[Category: Human immunodeficiency virus 1]] | ||
[[Category: Unge, T.]] | [[Category: Unge, T.]] | ||
[[Category: Dimer]] | [[Category: Dimer]] | ||
[[Category: Hydrolase-hydrolase inhibitor complex]] | |||
[[Category: Protein-inhibitor complex]] | [[Category: Protein-inhibitor complex]] | ||
Revision as of 16:51, 26 July 2012
HIV-1 protease in complex with the inhibitor bea403
Template:ABSTRACT PUBMED 15560801
About this Structure
1ec0 is a 2 chain structure of Virus protease with sequence from Human immunodeficiency virus 1. Full crystallographic information is available from OCA.
See Also
Reference
- Lindberg J, Pyring D, Lowgren S, Rosenquist A, Zuccarello G, Kvarnstrom I, Zhang H, Vrang L, Classon B, Hallberg A, Samuelsson B, Unge T. Symmetric fluoro-substituted diol-based HIV protease inhibitors. Ortho-fluorinated and meta-fluorinated P1/P1'-benzyloxy side groups significantly improve the antiviral activity and preserve binding efficacy. Eur J Biochem. 2004 Nov;271(22):4594-602. PMID:15560801 doi:10.1111/j.1432-1033.2004.04431.x